This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
DUROLANE is covered by Medicare and by many major Medicare Advantage Plans.
DUROLANE is now covered for 9 out of 10 Medicare patients, including members of many major Medicare Advantage plans, such as:‡49
-
Aetna® Medicare Advantage
-
Anthem® Medicare Advantage
-
Humana® Medicare Advantage
-
UnitedHealthcare® Medicare Advantage
If you suffer from osteoarthritis (OA) knee pain, DUROLANE can help you spend less time seeking relief—and more time doing what you love.
A single-injection hyaluronic acid (HA) therapy, DUROLANE offers important benefits for treatment of knee OA pain:
-
1 doctor’s visit, 1 injection
-
Up to 6 months of pain relief24
-
May delay the need for knee replacement surgery§12,50
Helpful resources:
Knee OA doesn’t have to stop you from living the life you want. Explore resources to help you stay active.
Learn about OA
Learn about rebates
Questions? Ask your healthcare provider about DUROLANE. Or use the form below to contact us.
Discover the HA portfolio that gives you the power of choice
How can we help you?
Fill out the form below and we will reach out to you shortly.
Disclaimer: Bioventus will never make your email address available to third parties, except to distribute requested materials. Any complaints or adverse reaction messages may be sent to Complaints@Bioventus.com.
‡As of January 1, 2024
§The study by Altman et al. 2015 does not contain data specific to DUROLANE
Summary of Indications for Use: GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.
GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.
Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.
Summary of Indications for Use: SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.
Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.